Campagnoli E - Search Results

1

Evaluation of radiological and pathological prognostic factors in surgically-treated patients with bronchoalveolar carcinoma.

Carretta A, Canneto B, Calori G, Ceresoli GL, Campagnoli E, Arrigoni G, Vagani A, Zannini P. Carretta A, et al. Among authors: campagnoli e. Eur J Cardiothorac Surg. 2001 Aug;20(2):367-71. doi: 10.1016/s1010-7940(01)00733-3. Eur J Cardiothorac Surg. 2001. PMID: 11463559

2

Gemcitabine and vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma.

Zucali PA, Ceresoli GL, Garassino I, De Vincenzo F, Cavina R, Campagnoli E, Cappuzzo F, Salamina S, Soto Parra HJ, Santoro A. Zucali PA, et al. Among authors: campagnoli e. Cancer. 2008 Apr 1;112(7):1555-61. doi: 10.1002/cncr.23337. Cancer. 2008. PMID: 18286536 Free article. Clinical Trial.

3

Phase II trial of alternating intravenous and oral vinorelbine in combination with cisplatin in advanced non-small cell lung cancer.

Campagnoli E, Garassino I, Santoro A, De Vincenzo F, Zucali PA, Ceresoli GL, Lutman FR, Alloisio M, Soto Parra HJ, Cavina R. Campagnoli E, et al. Invest New Drugs. 2007 Dec;25(6):559-64. doi: 10.1007/s10637-007-9067-2. Epub 2007 Jun 19. Invest New Drugs. 2007. PMID: 17576521 Clinical Trial.

4

EGFR tyrosine kinase inhibitors: a therapy for a few, for the majority or for all non-small cell lung cancer patients?

Finocchiaro G, Toschi L, Garassino I, De Vincenzo F, Campagnoli E, Zucali P, Cavina R, Ceresoli GL, Santoro A, Cappuzzo F. Finocchiaro G, et al. Among authors: campagnoli e. Expert Opin Med Diagn. 2007 Oct;1(2):183-91. doi: 10.1517/17530059.1.2.183. Expert Opin Med Diagn. 2007. PMID: 23489305

5

Short schedule of cisplatin and vinorelbine: a dose-finding study in non-small-cell lung cancer.

Zucali PA, Soto Parra HJ, Cavina R, Campagnoli E, Latteri F, De Vincenzo F, Ceresoli GL, Fazio M, Alloisio M, Santoro A. Zucali PA, et al. Among authors: campagnoli e. Oncology. 2006;71(3-4):229-36. doi: 10.1159/000106427. Epub 2007 Jul 23. Oncology. 2006. PMID: 17652944

6

Invasive ductal carcinoma of the breast with the "triple-negative" phenotype: prognostic implications of EGFR immunoreactivity.

Viale G, Rotmensz N, Maisonneuve P, Bottiglieri L, Montagna E, Luini A, Veronesi P, Intra M, Torrisi R, Cardillo A, Campagnoli E, Goldhirsch A, Colleoni M. Viale G, et al. Among authors: campagnoli e. Breast Cancer Res Treat. 2009 Jul;116(2):317-28. doi: 10.1007/s10549-008-0206-z. Epub 2008 Oct 7. Breast Cancer Res Treat. 2009. PMID: 18839307 Clinical Trial.

7

Activity of a specific inhibitor, gefitinib (Iressa, ZD1839), of epidermal growth factor receptor in refractory non-small-cell lung cancer.

Santoro A, Cavina R, Latteri F, Zucali PA, Ginanni V, Campagnoli E, Ferrari B, Morenghi E, Pedicini V, Roncalli M, Alloisio M, Ravasi G, Soto Parra HJ. Santoro A, et al. Among authors: campagnoli e. Ann Oncol. 2004 Jan;15(1):33-7. doi: 10.1093/annonc/mdh010. Ann Oncol. 2004. PMID: 14679116 Free article.

8

Analysis of epidermal growth factor receptor expression as a predictive factor for response to gefitinib ('Iressa', ZD1839) in non-small-cell lung cancer.

Parra HS, Cavina R, Latteri F, Zucali PA, Campagnoli E, Morenghi E, Grimaldi GC, Roncalli M, Santoro A. Parra HS, et al. Among authors: campagnoli e. Br J Cancer. 2004 Jul 19;91(2):208-12. doi: 10.1038/sj.bjc.6601923. Br J Cancer. 2004. PMID: 15187994 Free PMC article.

9

Cisplatin plus gemcitabine on days 1 and 4 every 21 days for solid tumors: result of a dose-intensity study.

Parra HS, Cavina R, Latteri F, Campagnoli E, Morenghi E, Torri W, Brambilla G, Alloisio M, Santoro A. Parra HS, et al. Among authors: campagnoli e. Invest New Drugs. 2007 Feb;25(1):57-62. doi: 10.1007/s10637-006-8220-7. Invest New Drugs. 2007. PMID: 16699975 Clinical Trial.

10

The "old drug" dacarbazine as a second/third line chemotherapy in advanced soft tissue sarcomas.

Zucali PA, Bertuzzi A, Parra HJ, Campagnoli E, Quagliuolo V, Santoro A. Zucali PA, et al. Among authors: campagnoli e. Invest New Drugs. 2008 Apr;26(2):175-81. doi: 10.1007/s10637-007-9086-z. Epub 2007 Sep 25. Invest New Drugs. 2008. PMID: 17898927

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48 results

Search Page

Filters